All episodes

Dr. H. Tarik Kani talks to Dr. Axel Dignass (Germany) about his recent publication about the impact of Ustekinumab on health-related quality of life in moderate-to-severe Crohn’s disease which was an open-label, multicenter, randomized study evaluated the quality of life prospectively in Crohn’s patients who treated with Ustekinumab.

Ahsen Ustaoglu talks to Dr Martjin Jong (the Netherlands) on their recent paper developing an image-based deep learning system for primary detection of early Barrett's neoplasia

Dr. H. Tarik Kani talks to Dr Gabriele Dragoni (Italy) about his recent paper about the comparison of two strategies for the management of postoperative recurrence in Crohn’s disease which was a multicenter study evaluated the two strategies which are using in postoperative follow-up.

Ahsen Ustaoglu talks to Dr Nik Dekkers and Dr Jurjen Boonstra (the Netherlands) on their recent study investigating suitable imaging biomarker targets to differentiate high-grade dysplasia (HGD) and T1 colorectal cancer (T1CRC) from low-grade dysplasia (LGD) in colorectal polyps.

H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.

Ahsen Ustaoglu talks to Dr Nathaniel Cohen (Israel) about his recent paper on treat to target and sequencing therapies in Crohn’s disease, part of the Special issue: Changing Paradigms in Management of Inflammatory Bowel Disease.

Iago Rodríguez-Lago talks to Dr Erchinger (Norway) about his recent paper about pancreatic enzyme treatment, where he and all co-authors have evaluated the adherence to guidelines in a European cross‐sectional observational study.

Iago Rodríguez-Lago talks to Dr Savarino (Italy) about his recent paper about functional bowel disorders with diarrhoea, where he and all co-authors have performed a Delphi consensus with experts from 10 European countries. This multinational group of European expertssummarize the current state of consensus on the definition, diagnosis, and managementof these disorders.

Katarzyna Pawlak talks to Dr Goessens (Belgium) about his recent paper on the efficacy and safety of combining biologic agents and small molecules in IBD, recognized with the UEG Journal 2022 Best Paper Award.

Iago Rodríguez-Lago talks to Dr Vujasinovic (Sweden) about the relationship between autoimmune pancreatitis and inflammatory bowel disease, that has been explored by his research group through an analysis of the experience from two referral centers and a systematic review of the literature.